000 01432 a2200397 4500
005 20250517215711.0
264 0 _c20190307
008 201903s 0 0 eng d
022 _a1756-8927
024 7 _a10.4155/fmc-2018-0090
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPulley, Jill M
245 0 0 _aAdvocating for mutually beneficial access to shelved compounds.
_h[electronic resource]
260 _bFuture medicinal chemistry
_c06 2018
300 _a1395-1398 p.
_bdigital
500 _aPublication Type: Editorial; Research Support, N.I.H., Extramural
650 0 4 _aAntidiuretic Hormone Receptor Antagonists
_xtherapeutic use
650 0 4 _aAnxiety Disorders
_xdrug therapy
650 0 4 _aDepressive Disorder, Major
_xdrug therapy
650 0 4 _aDrug Industry
650 0 4 _aDrug Repositioning
_xmethods
650 0 4 _aHumans
650 0 4 _aIndoles
_xtherapeutic use
650 0 4 _aPyrrolidines
_xtherapeutic use
650 0 4 _aReceptors, Vasopressin
_xtherapeutic use
700 1 _aJerome, Rebecca N
700 1 _aShirey-Rice, Jana K
700 1 _aZaleski, Nicole M
700 1 _aNaylor, Helen M
700 1 _aPruijssers, Andrea J
700 1 _aJackson, James C
700 1 _aBernard, Gordon R
700 1 _aHolroyd, Kenneth J
773 0 _tFuture medicinal chemistry
_gvol. 10
_gno. 12
_gp. 1395-1398
856 4 0 _uhttps://doi.org/10.4155/fmc-2018-0090
_zAvailable from publisher's website
999 _c28418063
_d28418063